PL4389116T3 - Farmaceutyczna wodna zawiesina flubendazolu - Google Patents

Farmaceutyczna wodna zawiesina flubendazolu

Info

Publication number
PL4389116T3
PL4389116T3 PL23151010.8T PL23151010T PL4389116T3 PL 4389116 T3 PL4389116 T3 PL 4389116T3 PL 23151010 T PL23151010 T PL 23151010T PL 4389116 T3 PL4389116 T3 PL 4389116T3
Authority
PL
Poland
Prior art keywords
flubendazole
aqueous suspension
pharmaceutical aqueous
pharmaceutical
suspension
Prior art date
Application number
PL23151010.8T
Other languages
English (en)
Inventor
Henricus Fransiscus Catharina MICHIELS
Brigitte Johanna Bernita Folmer
Stephan Jacob LEJEUNE
Original Assignee
Dechra Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dechra Ltd filed Critical Dechra Ltd
Publication of PL4389116T3 publication Critical patent/PL4389116T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PL23151010.8T 2022-12-23 2023-01-10 Farmaceutyczna wodna zawiesina flubendazolu PL4389116T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP22216470 2022-12-23

Publications (1)

Publication Number Publication Date
PL4389116T3 true PL4389116T3 (pl) 2026-03-02

Family

ID=84604275

Family Applications (1)

Application Number Title Priority Date Filing Date
PL23151010.8T PL4389116T3 (pl) 2022-12-23 2023-01-10 Farmaceutyczna wodna zawiesina flubendazolu

Country Status (10)

Country Link
EP (1) EP4389116B1 (pl)
DK (1) DK4389116T3 (pl)
ES (1) ES3046384T3 (pl)
FI (1) FI4389116T3 (pl)
HR (1) HRP20251177T1 (pl)
LT (1) LT4389116T (pl)
PL (1) PL4389116T3 (pl)
PT (1) PT4389116T (pl)
RS (1) RS67263B1 (pl)
SI (1) SI4389116T1 (pl)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2037914T3 (pl) 2006-06-14 2014-04-30 Intervet Int Bv Zawiesina zawierająca karbaminian benzoimidazolu i polisorbat
TWI580442B (zh) * 2011-10-19 2017-05-01 傑特大學 醫藥毫微懸浮物

Also Published As

Publication number Publication date
DK4389116T3 (da) 2025-10-13
SI4389116T1 (sl) 2025-12-31
ES3046384T3 (en) 2025-12-01
PT4389116T (pt) 2025-10-06
RS67263B1 (sr) 2025-10-31
HRP20251177T1 (hr) 2025-11-21
FI4389116T3 (fi) 2025-10-16
EP4389116A1 (en) 2024-06-26
LT4389116T (lt) 2025-10-27
EP4389116B1 (en) 2025-09-10

Similar Documents

Publication Publication Date Title
PL3994304T3 (pl) Sposób wytwarzania produktu celulozowego i produkt celulozowy
LT3993807T (lt) Vaistą apimančios vandeninės kompozicijos ph stabilizavimo būdas
EP3906019C0 (en) Pharmaceutical compositions of furosemide
EP4244818A4 (en) Disambiguation of poses
EP3930877C0 (en) PRODUCTION OF CONCENTRATED USED DIALYSATE
EP3799594A4 (en) PRODUCTION OF OLIGOSACCHARIDS
EP4003323A4 (en) STABILIZED FORMULATIONS OF 4-AMINO-3-SUBSTITUTED BUTANOIC ACID DERIVATIVES
EP3608670A4 (en) HYDROPHILE COLORING CELLULOSE MICROPARTICLES
EP4263939C0 (en) AQUEOUS DISPERSION OF ETHYLCELLULOSE
HUE065395T2 (hu) Mikromûanyagok elválasztása
PL3917749T3 (pl) Sposób wytwarzania mieszanek skrobi
IL285765A (en) Therapeutic uses of dulaglutide
PL4389116T3 (pl) Farmaceutyczna wodna zawiesina flubendazolu
IL311473A (en) Ophthalmic pharmaceutical compositions of roflumilast
IL305851A (en) Preparation of 2-chloro-4-fluoro-5-nitrobenzoic acid
EP4275007C0 (en) DRYING OF PHARMACEUTICAL POWDERS
EP4178717A4 (en) CONTINUOUS PRODUCTION OF NANOFORESTS
IL312073A (en) Pharmaceutical compositions of efruxifermin
IL313407A (en) Enzymatic decarbamoylation of glufosinate derivatives
IL313212A (en) Solid state forms of tavapadon and processes for preparation thereof
EP4228584C0 (en) Medication delivery
EP4192440C0 (en) TTS COMPRISING ESKETAMINE SUSPENSION
EP3760205A4 (en) AQUATIC SUSPENSION TYPE PHARMACEUTICAL PREPARATION
PL4231859T3 (pl) Sposób kontroli pałeczkowato ukształtowanych wyrobów
EP3500590A4 (en) PRODUCTION AND USE OF PHOSPHOETHANOLAMINE CELLULOSE AND DERIVATIVES